This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Avinger (AVGR) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Avinger (AVGR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks.com featured highlights include: JAKKS, Avinger, Energous, FireEye and Proteostasis
by Zacks Equity Research
Zacks.com featured highlights include: JAKKS, Avinger, Energous, FireEye and Proteostasis
5 Top Stocks With Rising P/E to Bet On
by Sanghamitra Saha
Forget undervalued stocks, play these top-ranked stocks with rising P/E.
Bet on Rising P/E Investing With These Top 5 Stocks
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Avinger (AVGR) Upgraded to Buy: Here's Why
by Zacks Equity Research
Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys
by Zacks Equity Research
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E for outsized gains.
Try Rising P/E Investing With 5 Top-Ranked Stocks
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Avinger (AVGR) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Top Ranked Momentum Stocks to Buy for October 24th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 24th.
Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Is Avinger (AVGR) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (AVGR) Outperforming Other Medical Stocks This Year?
Is Avinger (AVGR) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (AVGR) Outperforming Other Medical Stocks This Year?
Avinger (AVGR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Avinger (AVGR) closed at $0.58 in the latest trading session, marking a -0.62% move from the prior day.
Top Ranked Momentum Stocks to Buy for April 11th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 11th.
EDAP TMS (EDAP) Looks Good: Stock Adds 7.9% in Session
by Zacks Equity Research
EDAP TMS (EDAP) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Top Ranked Momentum Stocks to Buy for April 9th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 9th:
Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger
by Zacks Equity Research
Zacks.com featured highlights include: G-III, SP Plus, Penske Automotive, aTyr and Avinger
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E to realize outsized gains.
5 Top Rising P/E Stocks to Enjoy Solid Gains
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
by Zacks Equity Research
Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
5 Top-Ranked Rising P/E Stocks to Lure Investors
by Sanghamitra Saha
Inside the top-ranked stocks that have been exhibiting rising P/E ratios.
Align Technology (ALGN) Beats on Q1 Earnings and Revenues
by Zacks Equity Research
Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter.
Cerner (CERN) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Cerner Corp (CERN) reported adjusted first-quarter 2017 earnings of 56 cents per share, beating the Zacks Consensus Estimate of 53 cents.